In the case of drug-induced AKI with progression to end-stage renal disease (ESRD), the urinary EGF level continued to decrease until the patient was discharged, and the serum creatinine level remained high (Figure 3E). This evidence concerns the gene EGF and stage 5 chronic kidney disease.